Market Research Logo

Global Markets and Technologies for Advanced Drug Delivery Systems

Global Markets and Technologies for Advanced Drug Delivery Systems

The global advanced drug delivery market should grow from roughly $178.8 billion in 2015 to nearly $227.3 billion by 2020, with a compound annual growth rate (CAGR) of 4.9%.

This report provides:
An overview of the global market for drug delivery systems, including the market as seen by end users of different applications
Analyses of global market trends, with data from 2014, estimates for 2015, and projections of compound annual growth rates (CAGRs) through 2020
Discussion of the current state, setbacks, innovations, and the future needs of the market
Examination of the different categories of drug delivery, broken down by market shares of the leading manufacturers and/or suppliers, as well as acquisitions, mergers, and alliances by companies and global organizations
Analyses of the regulatory environment, and the technology involved, including the latest trends and developments•Profiles of major players in the industry


SCOPE OF REPORT

The report’s scope includes the following:
Key market analysis
Market dynamics (drivers and restraints)
Market estimation for the forecasted period (2015 through 2020)
Competitive developments and landscape
Regional analysis
Profiles of key market players
Patents

CHAPTER 1 INTRODUCTION
STUDY GOALS AND OBJECTIVES
REASONS FOR DOING THE STUDY
SCOPE OF REPORT
INTENDED AUDIENCE
INFORMATION SOURCES AND METHODOLOGY
ANALYST’S CREDENTIALS
RELATED BCC RESEARCH REPORTS
BCC RESEARCH WEBSITE
DISCLAIMER
CHAPTER 2 SUMMARY
SUMMARY TABLE GLOBAL ADVANCED DRUG DELIVERY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
SUMMARY FIGURE GLOBAL ADVANCED DRUG DELIVERY MARKET BY REGION, 2014-2020 ($ MILLIONS)
CHAPTER 3 OVERVIEW
ADVANCED DRUG DELIVERY MARKET EVOLUTION AND DYNAMICS
ADVANCED DRUG DELIVERY INDUSTRY LIFE/GROWTH STAGES
FIRST GENERATION - CONTROLLED/MODIFIED RELEASE TECHNOLOGIES
SECOND GENERATION - NEW WAVE OF ADVANCED DRUG DELIVERY
TECHNOLOGIES WITH EMERGENCE OF SMART DRUG DELIVERY
THIRD GENERATION - NEW FRONTIER OF ADVANCED DRUG DELIVERY WITH SIGNIFICANT ADVANCES IN MODIFIED DELIVERY SYSTEMS
MULTIPLE-RELEASE TECHNOLOGY MARKET
FIXED DOSE COMBINATION MULTIPLE RELEASE TECHNOLOGY – MAJOR
PHASE OF NEXT GENERATION ADVANCED DRUG DELIVERY MARKET.
MARKET DRIVERS AND RESTRAINTS
GLOBAL ADVANCED DRUG DELIVERY MARKET ANALYSIS
FIGURE 1 MARKET SHARE IN GLOBAL ADVANCED DRUG DELIVERY MARKET BY REGION, 2015 (%)
FIGURE 2 MARKET SHARE IN GLOBAL ADVANCED DRUG DELIVERY TECHNOLOGIES/SYSTEMS, 2015 (%)
FIGURE 3 MARKET SHARE IN GLOBAL ADVANCED DRUG DELIVERY TECHNOLOGIES/SYSTEMS BY ROUTE OF ADMINISTRATION (2015) (%)
COMPETITIVE LANDSCAPE
PATENT ANALYSIS
FIGURE 4 PATENT ANALYSIS BY PATENT JURISDICTION, 2014-DECEMBER 2015 (%)
CHAPTER 4 ADVANCED DRUG DELIVERY TECHNOLOGIES/SYSTEMS
MARKET
TABLE 1 GLOBAL ADVANCED DRUG DELIVERY TECHNOLOGIES MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
TABLE 2 GLOBAL ADVANCED DRUG DELIVERY TECHNOLOGIES MARKET BY TYPE, THROUGH 2020 ($ MILLIONS)
FIGURE 5 MARKET SHARE IN GLOBAL ADVANCED DRUG DELIVERY RELEASE TECHNOLOGIES/SYSTEMS, 2015 (%)
ADVANCED IMMEDIATE-RELEASE TECHNOLOGY
DRIVERS AND RESTRAINTS
TABLE 3 GLOBAL ADVANCED IMMEDIATE-RELEASE TECHNOLOGY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
MODIFIED DRUG DELIVERY
TABLE 4 GLOBAL MODIFIED-RELEASE TECHNOLOGY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
TABLE 5 GLOBAL MODIFIED-RELEASE TECHNOLOGY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
TARGETED DRUG DELIVERY TECHNOLOGY
Drivers and Restraints
Market Analysis
Future Outlook
Market Players
TABLE 6 GLOBAL TARGETED-RELEASE TECHNOLOGY MARKET BY DRUG DELIVERY VEHICLES, THROUGH 2020 ($ MILLIONS)
TABLE 7 GLOBAL TARGETED-RELEASE TECHNOLOGY MARKET BY ROUTE OF ADMINISTRATION, THROUGH 2020 ($ MILLIONS)
TABLE 8 GLOBAL TARGETED-RELEASE TECHNOLOGY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
EXTENDED DRUG RELEASE
TABLE 9 GLOBAL EXTENDED-RELEASE TECHNOLOGY MARKET BY DRUG DELIVERY VEHICLE, THROUGH 2020 ($ MILLIONS)
TABLE 10 GLOBAL EXTENDED-RELEASE TECHNOLOGY MARKET BY ROUTE OF ADMINISTRATION, THROUGH 2020 ($ MILLIONS)
TABLE 11 GLOBAL EXTENDED-RELEASE TECHNOLOGY MARKET BY TYPE, THROUGH 2020 ($ MILLIONS)
TABLE 12 GLOBAL EXTENDED-RELEASE TECHNOLOGY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
SUSTAINED AND CONTROLLED RELEASE DRUG DELIVERY SYSTEMS
Drivers and Restraints
Market Analysis and Future Outlook
Market Players
TABLE 13 GLOBAL SUSTAINED-RELEASE TECHNOLOGY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
TABLE 14 GLOBAL CONTROLLED-RELEASE TECHNOLOGY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
DELAYED RELEASE AND PULSATILE RELEASE DRUG DELIVERY
TECHNOLOGY
Market Analysis
Drivers and Restraints
Market Players
TABLE 15 GLOBAL DELAYED-RELEASE TECHNOLOGY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
TABLE 16 GLOBAL PULSATILE-RELEASE TECHNOLOGY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
CHAPTER 5 MARKET BY ROUTE OF ADMINISTRATION
TABLE 17 GLOBAL ADVANCED DRUG DELIVERY MARKET BY ROUTES OF ADMINISTRATION, THROUGH 2020 ($ MILLIONS)
FIGURE 6 MARKET SHARE IN GLOBAL ADVANCED DRUG DELIVERY TECHNOLOGIES/SYSTEMS BY ROUTE OF ADMINISTRATION, 2015 (%)
ORAL DRUG DELIVERY MARKET
MARKET DRIVERS AND RESTRAINTS/CHALLENGES
MARKET ANALYSIS - INNOVATIONS, DEVELOPMENTS AND KEY COMPETITIVE
FACTORS
TABLE 18 EXAMPLES OF ORAL FAST-DISSOLVED/DISINTEGRATED (FDTS)
TECHNOLOGIES AND PRODUCTS
Opportunities/Future Outlook
MARKET PLAYERS
TABLE 19 GLOBAL ORAL ADVANCED DRUG DELIVERY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
PARENTERAL/INJECTABLE DRUG DELIVERY MARKET
DRIVERS AND RESTRAINTS
MARKET ANALYSIS - INNOVATIONS, DEVELOPMENTS AND KEY COMPETITIVE
FACTORS
FUTURE OUTLOOK/OPPORTUNITIES
MARKET PLAYERS
TABLE 20 GLOBAL INJECTABLE ADVANCED DRUG DELIVERY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
TOPICAL DRUG DELIVERY MARKET
MARKET ANALYSIS - DEVELOPMENTS AND INNOVATIONS
MARKET DRIVERS AND RESTRAINTS
MARKET PLAYERS
TABLE 21 GLOBAL TOPICAL ADVANCED DRUG DELIVERY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
TRANSDERMAL DRUG DELIVERY
MARKET DRIVERS AND RESTRAINTS
MARKET ANALYSIS - PRODUCT EXAMPLES, INNOVATION AND FUTURE
OUTLOOK
FUTURE OUTLOOK/OPPORTUNITIES
MARKET PLAYERS
TABLE 22 GLOBAL TRANSDERMAL ADVANCED DRUG DELIVERY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
TRANSMUCOSAL MARKET
MARKET DRIVERS AND RESTRAINTS
MARKET PLAYERS
TABLE 23 GLOBAL TRANSMUCOSAL ADVANCED DRUG DELIVERY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
TABLE 24 GLOBAL TRANSMUCOSAL ADVANCED DRUG DELIVERY MARKET BY TYPE, THROUGH 2020 ($ MILLIONS)
NASAL AND PULMONARY MARKET
Market Drivers and Analysis
TABLE 25 GLOBAL TRANSMUCOSAL NASAL AND PULMONARY ADVANCED DRUG DELIVERY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
OCULAR DRUG DELIVERY
Market Analysis
TABLE 26 GLOBAL TRANSMUCOSAL OCULAR ADVANCED DRUG DELIVERY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
ORAL - BUCCAL DRUG DELIVERY
Market Analysis
TABLE 27 GLOBAL TRANSMUCOSAL ORAL BUCCAL ADVANCED DRUG DELIVERY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
VAGINAL DRUG DELIVERY
TABLE 28 GLOBAL TRANSMUCOSAL VAGINAL ADVANCED DRUG DELIVERY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
RECTAL DRUG DELIVERY
TABLE 29 GLOBAL TRANSMUCOSAL RECTAL ADVANCED DRUG DELIVERY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
IMPLANTS DRUG DELIVERY
MARKET DRIVERS AND RESTRAINTS
MARKET ANALYSIS AND FUTURE OUTLOOK
MARKET PLAYERS
TABLE 30 GLOBAL IMPLANTS ADVANCED DRUG DELIVERY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
CONTRACEPTIVE DEVICES
TABLE 31 GLOBAL CONTRACEPTIVE DEVICES FOR ADVANCED DRUG DELIVERY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
CHAPTER 6 MARKET BY DRUG DELIVERY VEHICLES/CARRIERS
TABLE 32 GLOBAL ADVANCED DRUG DELIVERY VEHICLES/CARRIERS MARKET BY TYPE, THROUGH 2020 ($ MILLIONS)
FIGURE 7 MARKET SHARE IN GLOBAL ADVANCED DRUG DELIVERY MARKET BY DRUG VEHICLES/CARRIERS, 2015 (%)
LIPOSOMES
MARKET ANALYSIS AND FUTURE OUTLOOK
TABLE 33 GLOBAL LIPOSOMES MARKET IN ADVANCED DRUG DELIVERY BY REGION, THROUGH 2020 ($ MILLIONS)
POLYMERIC THERAPEUTICS
TABLE 34 GLOBAL POLYMERIC THERAPEUTICS MARKET IN ADVANCED DRUG DELIVERY BY REGION, THROUGH 2020 ($ MILLIONS)
TABLE 35 GLOBAL POLYMERIC THERAPEUTICS MARKET IN ADVANCED DRUG DELIVERY BY TYPE, THROUGH 2020 ($ MILLIONS)
MICELLES AND DENDRIMERS
Polymeric Micelles (Micelles)
Market Analysis
TABLE 36 GLOBAL POLYMERIC MICELLES MARKET IN ADVANCED DRUG DELIVERY BY REGION, THROUGH 2020 ($ MILLIONS)
Dendrimers
Market Analysis
TABLE 37 GLOBAL DENDRIMERS MARKET IN ADVANCED DRUG DELIVERY BY REGION, THROUGH 2020 ($ MILLIONS)
POLYMERS (POLYMERIC DRUG DELIVERY)
Market Analysis
Reservoir-based Systems
Monolithic Matrix Systems
Polymer-drug Conjugate Systems
TABLE 38 GLOBAL POLYMERIC DRUGS MARKET IN ADVANCED DRUG DELIVERY BY REGION, THROUGH 2020 ($ MILLIONS)
TABLE 39 GLOBAL POLYMERIC DRUGS MARKET IN ADVANCED DRUG DELIVERY BY TYPE OF DRUG SYSTEM, THROUGH 2020 ($ MILLIONS)
NANOCARRIERS/NANOPARTICLES
TABLE 40 GLOBAL NANOCARRIERS/NANOPARTICLES MARKET IN ADVANCED DRUG DELIVERY BY REGION, THROUGH 2020 ($ MILLIONS)
MICROPARTICLES/MICROSPHERES
TABLE 41 GLOBAL MICROPARTICLES/MICROSPHERES MARKET IN ADVANCED DRUG DELIVERY BY REGION, THROUGH 2020 ($ MILLIONS)
MONOCLONAL ANTIBODIES (MAbs)
TABLE 42 GLOBAL MONOCLONAL ANTIBODIES MARKET IN ADVANCED DRUG DELIVERY BY REGION, THROUGH 2020 ($ MILLIONS)
PRODRUGS
TABLE 43 GLOBAL PRODRUGS MARKET IN ADVANCED DRUG DELIVERY BY REGION, THROUGH 2020 ($ MILLIONS)
TABLE 44 GLOBAL PRODRUGS MARKET IN ADVANCED DRUG DELIVERY BY TYPE, THROUGH 2020 ($ MILLIONS)
OTHERS
TABLE 45 GLOBAL OTHER DRUG DELIVERY VEHICLES/CARRIERS MARKET IN ADVANCED DRUG DELIVERY BY REGION, THROUGH 2020 ($ MILLIONS)
CHAPTER 7 MARKET BY APPLICATIONS
TABLE 46 GLOBAL ADVANCED DRUG DELIVERY MARKET BY APPLICATION, THROUGH 2020 ($ MILLIONS)
FIGURE 8 MARKET SHARE IN GLOBAL ADVANCED DRUG DELIVERY TECHNOLOGIES/SYSTEMS BY APPLICATION, 2015 (%)
CARDIOVASCULAR
TABLE 47 GLOBAL ADVANCED DRUG DELIVERY CARDIOVASCULAR APPLICATIONS MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
ONCOLOGY MARKET
TABLE 48 GLOBAL ADVANCED DRUG DELIVERY ONCOLOGY APPLICATIONS MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
GASTROINTESTINAL DISORDERS
TABLE 49 GLOBAL ADVANCED DRUG DELIVERY GASTROINTESTINAL APPLICATIONS MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
UROLOGY
TABLE 50 GLOBAL ADVANCED DRUG DELIVERY UROLOGY APPLICATIONS MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
DIABETES
TABLE 51 GLOBAL ADVANCED DRUG DELIVERY DIABETES APPLICATIONS MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
DERMATOLOGY
TABLE 52 GLOBAL ADVANCED DRUG DELIVERY DERMATOLOGY APPLICATIONS MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
CENTRAL NERVOUS SYSTEM
TABLE 53 GLOBAL ADVANCED DRUG DELIVERY CENTRAL NERVOUS SYSTEM APPLICATIONS MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
RESPIRATORY DRUG DELIVERY SYSTEMS
TABLE 54 GLOBAL ADVANCED DRUG DELIVERY RESPIRATORY APPLICATIONS MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
INFLAMMATORY DISEASES AND ALLERGIES
TABLE 55 GLOBAL ADVANCED DRUG DELIVERY INFLAMMATORY DISEASES AND ALLERGIES APPLICATIONS MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
OPHTHALMOLOGY
TABLE 56 GLOBAL ADVANCED DRUG DELIVERY OPHTHALMOLOGY APPLICATIONS MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
VIRAL AND BACTERIAL DISEASES
TABLE 57 GLOBAL ADVANCED DRUG DELIVERY VIRAL AND BACTERIAL DISEASES APPLICATIONS MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
HORMONE REPLACEMENT THERAPY AND GYNECOLOGY
TABLE 58 GLOBAL ADVANCED DRUG DELIVERY HORMONAL REPLACEMENT THERAPY AND GYNECOLOGY APPLICATIONS MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
OTHER THERAPEUTIC CATEGORIES
TABLE 59 GLOBAL ADVANCED DRUG DELIVERY OTHER THERAPEUTIC APPLICATIONS MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
CHAPTER 8 COMPETITIVE DEVELOPMENTS
INTRODUCTION
FIGURE 9 DEVELOPMENTS IN GLOBAL PATIENT MONITORING DEVICES MARKET, 2013-DECEMBER 2015 (%)
TABLE 60 DEVELOPMENTS - PRODUCT LAUNCH/APPROVAL/UPDATE, 2013- DEC 2015
TABLE 61 DEVELOPMENTS – COLLABORATIONS/PARTNERS
HIPS/AGREEMENTS, 2013-DEC 2015
TABLE 62 DEVELOPMENTS - ACQUISITIONS AND MERGERS, 2013- DEC 2015
TABLE 63 DEVELOPMENTS - MISCELLANEOUS, 2013- OCT 2015
CHAPTER 9 REGIONAL ANALYSIS
NORTH AMERICA
TABLE 64 NORTH AMERICAN ADVANCED DRUG DELIVERY MARKET BY TECHNOLOGY, THROUGH 2020 ($ MILLIONS)
TABLE 65 NORTH AMERICAN ADVANCED DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION, THROUGH 2020 ($ MILLIONS)
TABLE 66 NORTH AMERICAN ADVANCED DRUG DELIVERY MARKET BY APPLICATION, THROUGH 2020 ($ MILLIONS)
TABLE 67 NORTH AMERICAN ADVANCED DRUG DELIVERY MARKET BY DRUG VEHICLES/CARRIERS, THROUGH 2020 ($ MILLIONS)
EUROPE
TABLE 68 EUROPEAN ADVANCED DRUG DELIVERY MARKET BY TECHNOLOGY, THROUGH 2020 ($ MILLIONS)
TABLE 69 EUROPEAN ADVANCED DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION, THROUGH 2020 ($ MILLIONS)
TABLE 70 EUROPEAN ADVANCED DRUG DELIVERY MARKET BY APPLICATIONS, THROUGH 2020 ($ MILLIONS)
TABLE 71 EUROPEAN ADVANCED DRUG DELIVERY MARKET BY DRUG VEHICLES/CARRIERS, THROUGH 2020 ($ MILLIONS)
ASIA-PACIFIC
TABLE 72 ASIA-PACIFIC ADVANCED DRUG DELIVERY MARKET BY TECHNOLOGY, THROUGH 2020 ($ MILLIONS)
TABLE 73 ASIA-PACIFIC ADVANCED DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION, THROUGH 2020 ($ MILLIONS)
TABLE 74 ASIA-PACIFIC ADVANCED DRUG DELIVERY MARKET BY APPLICATIONS, THROUGH 2020 ($ MILLIONS)
TABLE 75 ASIA-PACIFIC ADVANCED DRUG DELIVERY MARKET BY DRUG VEHICLES/CARRIERS, THROUGH 2020 ($ MILLIONS)
REST OF THE WORLD (ROW)
TABLE 76 ROW ADVANCED DRUG DELIVERY MARKET BY TECHNOLOGY, THROUGH 2020 ($ MILLIONS)
TABLE 77 ROW ADVANCED DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION, THROUGH 2020 ($ MILLIONS)
TABLE 78 ROW ADVANCED DRUG DELIVERY MARKET BY APPLICATIONS, THROUGH 2020 ($ MILLIONS)
TABLE 79 ROW ADVANCED DRUG DELIVERY MARKET BY DRUG VEHICLES/CARRIERS, THROUGH 2020 ($ MILLIONS)
CHAPTER 10 APPENDIX
TABLE 80 LIST (EXAMPLES) OF PATENTS, 2015
TABLE 81 LIST (EXAMPLES) PATENTS, 2014
CHAPTER 11 COMPANY PROFILES
3M COMPANY
ABBOTT LABORATORIES
ALLERGAN PLC
AKELA PHARMA INC.
ALCON INC. (NOVARTIS COMPANY)
AMGEN INC.
A.P. PHARMA/ HERON THERAPEUTICS, INC.
APTALIS PHARMA INC. /ADARE PHARMACEUTICALS
ALKERMES
ASTELLAS PHARMA INC.
ASTRAZENECA PLC
BAUSCH & LOMB
BAXTER INTERNATIONAL INC.
BAYER HEALTHCARE PHARMACEUTICALS
BIOGEN IDEC
BIOSANTE PHARMACEUTICALS INC.
BOEHRINGER INGELHEIM
BOSTON SCIENTIFIC
BRISTOL-MYERS SQUIBB
CAPSUGEL
CATALENT
CELGENE CORP.
EISAI CO. LTD.
ELAN DRUG TECHNOLOGIES/PERRIGO COMPANY
ENZON PHARMACEUTICALS
ELIXIR MEDICAL CORP.
FLAMEL TECHNOLOGIES
GENENTECH INC.
GENEREX BIOTECHNOLOGY CORP.
GENZYME CORP.
GILEAD SCIENCES INC.
GLAXOSMITHKLINE PLC
HISAMITSU PHARMACEUTICAL CO. INC.
ELI LILLY & IMCLONE SYSTEMS
JANSSEN BIOTECH INC.
JOHNSON & JOHNSON
KEMPHARM INC.
KYOTO MEDICAL PLANNING CO. LTD.
MANNKIND CORP.
MEDTRONIC
MERCK & CO.
MYLAN LABORATORIES INC.
NEKTAR THERAPEUTICS
NEWGEN BIOPHARMA
NOVARTIS AG
NOVAVAX INC.
NOVEN PHARMACEUTICALS INC.
PAR PHARMACEUTICAL COMPANIES INC.
PDL BIOPHARMA INC.
PFIZER INC.
ROCHE HOLDING AG
SANOFI SA
SKYEPHARMA
TEVA PHARMACEUTICAL INDUSTRIES LTD.
THERAJECT INC.
VALEANT PHARMACEUTICALS INTERNATIONAL INC.
XEL PHARMACEUTICALS INC.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report